3 years ago
MRNA
AnalystsTyler Van BurenTyler Van Buren's Stock Forecasts
AnalystsTyler Van Buren
Analyst Ranking
Top 30%
#1645 out of 5511 analysts
Average Return
+2.05%
Win Rate
47%36 out of 76
Risk vs Reward
Poor
Good
Tyler Van Buren's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Bridgebio Pharma IncBBIO | +197.38% | $11.44 | $34.02 | 2023-02-06 - 2024-02-06 | Buy |
Mbx Biosciences IncMBX | +196.22% | $20.62 | $61.08 | 2025-11-04 - 2026-09-15 | Strong Buy |
Arcellx IncACLX | +154.28% | $34.14 | $86.81 | 2023-10-30 - 2024-10-30 | Buy |
Apogee Therapeutics IncAPGE | +88.07% | $21.46 | $40.36 | 2023-08-08 - 2024-08-08 | Buy |
Spyre Therapeutics IncSYRE | +80.85% | $15.72 | $28.43 | 2023-11-29 - 2024-11-29 | Buy |
Tyler Van Buren Analyst Color
Get additional color on Tyler Van Buren's coverage of popular stocks
5 years ago
MRNA
Tyler Van Buren's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Korsana Biosciences IncKRSA | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 days ago |
Braveheart Bio IncBRVE | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 16 days ago |
Bridgebio Pharma IncBBIO | 3 | Strong Buy | $110.00 | +60.84% | Maintains | a month ago |
Travere Therapeutics IncTVTX | 4 | Strong Buy | $75.00 | +19.98% | Maintains | a month ago |
Crinetics Pharmaceuticals IncCRNX | 1 | Hold | N/A | N/A | Downgrades | 2 months ago |
Apogee Therapeutics IncAPGE | 2 | Hold | N/A | N/A | Downgrades | 3 months ago |
Odyssey Therapeutics IncODTX | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 3 months ago |
Regeneron Pharmaceuticals IncREGN | 8 | Strong Buy | $960.00 | +24.01% | Maintains | 5 months ago |
Soleno Therapeutics IncSLNO | 2 | Hold | $53.00 | -0.02% | Downgrades | 5 months ago |
Biohaven LtdBHVN | 4 | Strong Buy | $30.00 | +143.11% | Maintains | 6 months ago |
Arcutis Biotherapeutics IncARQT | 1 | Strong Buy | $35.00 | +48.87% | Maintains | 7 months ago |
Crispr Therapeutics AgCRSP | 3 | Hold | $45.00 | -13.18% | Maintains | 7 months ago |
C4 Therapeutics IncCCCC | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 9 months ago |
Mbx Biosciences IncMBX | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 10 months ago |
Gilead Sciences IncGILD | 5 | Strong Buy | $125.00 | -14.56% | Maintains | a year ago |
Ideaya Biosciences IncIDYA | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | a year ago |
Cg Oncology IncCGON | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Keros Therapeutics IncKROS | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Bicara Therapeutics IncBCAX | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Oruka Therapeutics IncORKA | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Moderna IncMRNA | 6 | Hold | $60.00 | N/A | Maintains | 2 years ago |
Artiva Biotherapeutics IncARTV | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Cartesian Therapeutics IncRNAC | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Tectonic Therapeutic IncTECX | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Newamsterdam Pharma Co NvNAMS | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Cargo Therapeutics IncCRGX | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Spyre Therapeutics IncSYRE | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Arcellx IncACLX | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Reata Pharmaceuticals IncRETA | 1 | Buy | $140.00 | N/A | Initiates Coverage On | 3 years ago |
Acelyrin IncSLRN | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Deciphera Pharmaceuticals IncDCPH | 2 | Buy | $30.00 | N/A | Maintains | 4 years ago |
Fate Therapeutics IncFATE | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Immunocore Holdings PLCIMCR | 1 | Buy | $70.00 | N/A | Initiates Coverage On | 4 years ago |
Zentalis Pharmaceuticals IncZNTL | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Turning Point Therapeutics IncTPTX | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Arvinas IncARVN | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Tyra Biosciences IncTYRA | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Essa Pharma IncEPIX | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 6 years ago |
Gyre Therapeutics IncGYRE | 1 | Strong Buy | $225.00 | N/A | Initiates Coverage On | 6 years ago |
Gracell Biotechnologies IncGRCL | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 6 years ago |
Aligos Therapeutics IncALGS | 1 | Strong Buy | $875.00 | N/A | Initiates Coverage On | 6 years ago |
Beone Medicines LtdONC | 2 | Strong Sell | $185.00 | N/A | Downgrades | 6 years ago |
Mirati Therapeutics IncMRTX | 1 | Strong Buy | $210.00 | N/A | Maintains | 6 years ago |
Inozyme Pharma IncINZY | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 6 years ago |
Nurix Therapeutics IncNRIX | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 6 years ago |
Neurogene IncNGNE | 2 | Strong Buy | $150.00 | N/A | Maintains | 6 years ago |
Tcr2 Therapeutics IncTCRR | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 6 years ago |
Poseida Therapeutics IncPSTX | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 6 years ago |
Akouos IncAKUS | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 6 years ago |
Cypherpunk Technologies IncCYPH | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 6 years ago |
Pliant Therapeutics IncPLRX | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 6 years ago |
Harpoon Therapeutics IncHARP | 1 | Strong Buy | $350.00 | N/A | Initiates Coverage On | 6 years ago |
Gossamer Bio IncGOSS | 1 | Strong Buy | $2,400.00 | N/A | Initiates Coverage On | 6 years ago |
Theravance Biopharma IncTBPH | 1 | Strong Buy | $35.00 | N/A | Maintains | 7 years ago |
Adverum Biotechnologies IncADVM | 1 | Strong Buy | $200.00 | N/A | Reiterates | 7 years ago |
Omeros CorpOMER | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Alder Biopharmaceuticals IncALDR | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 9 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Neos Therapeutics IncNEOS | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 9 years ago |
Aerie Pharmaceuticals IncAERI | 1 | Buy | $70.00 | N/A | Initiates Coverage On | 10 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.